Publications (150,548)

Search

Improving the Safety of DIEP Flap Transplantation: Detailed Perforator Anatomy Study Using Preoperative CTA†

Frank K, Stroebel A, Ludolph I, Hauck T, May M, Beier J, Horch RE, Arkudas A (2022)

Journal article

Serial T2-Weighted Thoracic and Abdominal Lymphatic Imaging in Fontan Patients—New Insights into Dynamics of Lymphatic Abnormalities after Total Cavopulmonary Connection

Moosmann J, Schroeder C, Rompel O, Purbojo A, Dittrich S (2022)

Journal article

A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study)

Grünwald V, Hilser T, Meiler J, Goebell P, Ivanyi P, Strauss A, Hartmann A, et al. (2022)

Journal article

EROSITA study of the globular cluster 47 Tucanae

Saeedi S, Liu T, Knies J, Sasaki M, Becker W, Bulbul E, Dennerl K, et al. (2022)

Journal article

Optimization of Electrical Oscillators for an Efficient Operation of Resonant Piezoelectric Sensors

Wich M, Hubert F, Helmerich J, Rupitsch SJ (2022)

Conference contribution, Conference Contribution

Ovarian function in young patients (pts) treated with postneoadjuvant palbociclib (PAL) and endocrine therapy (ET) for hormone receptor (HR)-positive, HER2-negative early breast cancer (BC): Explorative analysis in Penelope-B

Furlanetto J, Marme F, Thode C, Nekljudova V, Liu Y, Jimenez MM, Reimer T, et al. (2022)

Conference contribution

Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment

Marme F, Hanusch C, Furlanetto J, Morris P, Link T, Denkert C, Fasching P, et al. (2022)

Conference contribution

Intermediate biopsies during neoadjuvant chemotherapy for breast cancer to predict patient outcome

Sinn BV, Untch M, Karn T, Van Mackelenbergh M, Huober J, Sychra K, Schmitt WD, et al. (2022)

Conference contribution

An Analysis of the Use Pattern of Hyperthermia (HT) in Combination with Radio(chemo)therapy or Chemotherapy in European HT Centers

Ademaj A, Veltsista DP, Marder D, Haelg RA, Puric E, Brunner TB, Crezee H, et al. (2022)

Conference contribution

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: Phase IIIb LUCY final analysis

Balmana J, Fasching P, Delaloge S, Park YH, Eisen A, Bourgeois H, Kemp Z, et al. (2022)

Conference contribution

‹ 1 ... 2,284 2,285 2,286 2,287 2,288 ... 15,055 ›